Literature DB >> 1912612

Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines.

J R Pasqualini1, B L Nguyen.   

Abstract

The effect of the anti-estrogens ICI 164,384 and tamoxifen on the estradiol (E2) concentration after incubation of estrone sulfate (E1-S) with different hormone-dependent (MCF-7 and T-47D) and hormone-independent (MDA-MD-231 and MDA-MB-436) mammary cancer cells, as well as the estrone sulfatase activity in these various cell lines, are presented. The anti-estrogen ICI 164,384 decreased very significantly the concentration of E2 after incubation of E1-S with MCF-7 (control, mean +/- SE: 100 +/- 24 pg/mg DNA; + ICI 164,384 [10(-6)M]: 7 +/- 2 pg/mg DNA). This effect was much more intense than with tamoxifen. A similar effect was observed with T-47D cells. However, no significant effect was observed in the hormone-independent cells. In the intact cell, estrone sulfatase activity was very intense in the hormone-dependent cells, but very small in the hormone-independent cells. However, this activity became very strong after homogenization in the hormone-independent cells. The data suggest that estrone sulfate can play an important role on the bioavailability of E2 in hormone-dependent breast cancer, and that understanding the control of estrone sulfatase activity can open new knowledge of the estrogen responses and new possibilities of therapeutic application in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912612     DOI: 10.1007/bf01980971

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Effects of plasma estrogen sulfates in mammary cancer cells.

Authors:  F Vignon; M Terqui; B Westley; D Derocq; H Rochefort
Journal:  Endocrinology       Date:  1980-04       Impact factor: 4.736

3.  Steroid sulfatase activities in human breast tumors.

Authors:  T L Dao; C Hayes; P R Libby
Journal:  Proc Soc Exp Biol Med       Date:  1974-06

4.  Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization.

Authors:  R Cailleau; M Olivé; Q V Cruciger
Journal:  In Vitro       Date:  1978-11

5.  Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells.

Authors:  J R Pasqualini; C Gelly; F Lecerf
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 6.  Importance of estrogen sulfates in breast cancer.

Authors:  J R Pasqualini; C Gelly; B L Nguyen; C Vella
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

7.  Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.

Authors:  E Samojlik; R J Santen; T J Worgul
Journal:  Steroids       Date:  1982-05       Impact factor: 2.668

8.  Steroidal pure antioestrogens.

Authors:  A E Wakeling; J Bowler
Journal:  J Endocrinol       Date:  1987-03       Impact factor: 4.286

9.  Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma.

Authors:  L Tseng; J Mazella; L Y Lee; M L Stone
Journal:  J Steroid Biochem       Date:  1983-10       Impact factor: 4.292

10.  Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.

Authors:  O Prost; M O Turrel; N Dahan; C Craveur; G L Adessi
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

View more
  3 in total

Review 1.  Hormone resistance, invasiveness, and metastatic potential in breast cancer.

Authors:  R Clarke; E W Thompson; F Leonessa; J Lippman; M McGarvey; T L Frandsen; N Brünner
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).

Authors:  B L Nguyen; G Chetrite; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 3.  Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression.

Authors:  R Clarke; T Skaar; K Baumann; F Leonessa; M James; J Lippman; E W Thompson; C Freter; N Brunner
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.